Biofrontera News

Analysts' Top Healthcare Picks: Biofrontera (BFRI), Alpine Immune Sciences (ALPN)

TipRanksMar 19 06:50 ET

Benchmark Reiterates Buy on Biofrontera, Maintains $18 Price Target

BenzingaAug 31, 2023 08:42 ET

Biofrontera Analyst Ratings

BenzingaAug 31, 2023 08:42 ET

Benchmark Adjusts Biofrontera's Price Target to $18 From $140, Keeps Buy Rating

MT NewswiresJul 5, 2023 08:00 ET

Benchmark Maintains Buy on Biofrontera, Lowers Price Target to $18

BenzingaJul 5, 2023 07:50 ET

Analysts Offer Insights on Healthcare Companies: Outset Medical (OM), Biofrontera (BFRI) and 2seventy Bio (TSVT)

TipRanksMay 15, 2023 16:31 ET

Benchmark Reiterates Buy on Biofrontera, Maintains $7 Price Target

BenzingaMay 15, 2023 09:29 ET

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), Jasper Therapeutics (JSPR) and Biofrontera (BFRI)

TipRanksMar 9, 2023 11:36 ET

Benchmark Adjusts Price Target on Biofrontera to $7 From $11, Reiterates Buy Rating

MT NewswiresJan 31, 2023 10:22 ET

Benchmark Reiterates Buy on Biofrontera, Lowers Price Target to $7

Benzinga Real-time NewsJan 31, 2023 09:43 ET

Biofrontera Analyst Ratings

Benzinga Analyst RatingsJan 31, 2023 09:42 ET

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Biofrontera (BFRI)

TipRanksJul 10, 2022 05:30 ET